Moderna (MRNA) is trading higher in the pre-market Thursday after increasing the financial guidance for the company’s blockbuster COVID-19 vaccine, branded as Spikevax. Ahead of its.
Moderna Announces Clinical and Program Updates at 3rd Annual Vaccines Day newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
COVID-19 vaccine Phase 2/3 study in children 6 months to under 6 years has successfully met its primary endpoint with robust neutralizing antibody titers similar to adults. Moderna is moving forward with
Moderna said it has signed vaccine purchase agreements worth $18.5 billion for this year, along with options for another $3.5 billion, including booster shots.
Coronavirus: The EU and AstraZeneca agree on COVID-19 vaccine supply and on ending litigation eureporter.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eureporter.co Daily Mail and Mail on Sunday newspapers.